fingolimod 1a pharma 0,5 mg – hartkapseln
1a pharma gmbh - fingolimodhydrochlorid -
inzolfi 0,5 mg – hartkapseln
sandoz gmbh - fingolimodhydrochlorid -
fingolimod mylan
mylan ireland limited - fingolimod hydrochloride - multiple sklerose, schubförmig-remittierender - immunsuppressiva - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 und 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
fingod 0,5 mg hartkapseln
tad pharma gmbh (3044021) - fingolimodhydrochlorid - hartkapsel - 0,5 mg - teil 1 - hartkapsel; fingolimodhydrochlorid (30117) 0,56 milligramm
fingolimod puren 0,5 mg hartkapseln
puren pharma gmbh & co. kg (8034441) - fingolimodhydrochlorid - hartkapsel - 0,5 mg - teil 1 - hartkapsel; fingolimodhydrochlorid (30117) 0,56 milligramm
fingolimod tillomed 0,5 mg hartkapseln
tillomed pharma gmbh (8132043) - fingolimodhydrochlorid - hartkapsel - 0,5 mg - teil 1 - hartkapsel; fingolimodhydrochlorid (30117) 0,56 milligramm
fingolimod bluefish 0,5 mg hartkapseln
bluefish pharmaceuticals ab - fingolimodhydrochlorid -
fingolimod 1a pharma 0,25 mg - hartkapseln
1a pharma gmbh - fingolimodhydrochlorid -
inzolfi 0,25 mg - hartkapseln
sandoz gmbh - fingolimodhydrochlorid -
fingolimod devatis 0,5 mg hartkapseln
devatis gmbh (8160507) - fingolimodhydrochlorid - hartkapsel - 0,5 mg - teil 1 - hartkapsel; fingolimodhydrochlorid (30117) 0,56 milligramm